Daniel Bradbury
Independent Director
Member of the Board of Directors since 2019
Nationality: U.S.
Professional Experience
- Executive Chairman, former CEO and Co-Founder of Equillium Inc., a company developing products to treat severe autoimmune and inflammatory disorders
- Managing Member, BioBrit LLC
- Member, Board of Trustees, Keck Graduate Institute, U.S.
- Director, Vivani Medical, Inc, and several private companies and philanthropic organizations
- Board Chairman, Castle Biosciences Inc & Biolinq Inc, Sensulin LLC, Del Nova, Inc., Persephone Biosciences
- Member, Advisory Council, Rady School of Management, San Diego, U.S.
- Life sciences executive with over 38 years of experience in creating and implementing strategies and transforming businesses
- Former CEO, Amylin Pharmaceuticals, a leading metabolic disease company, acquired by Bristol Myers Squibb in 2012
Recognitions
- Recipient of Director of the Year Award from Corporate Directors Forum (2012)
- Recipient of Director of the Year Award from Corporate Directors Forum (2012)
- EY’s Entrepreneur of the Year Finalist (2012)
Education
- International Executive Program, INSEAD, France
- Diploma in Management Studies, University of West London, UK
- Bachelor of Pharmacy, Nottingham University, UK
